04/08/2026
Congratulations to Ulrich Steidl, MD, PhD, on his appointment as Director of the Montefiore Einstein Comprehensive Cancer Center and Vice President of Cancer Medicine at Montefiore Einstein.
Dr. Steidl steps into the role after serving as interim director, bringing a strong record of leadership across MECCC and Montefiore Einstein at large. He will continue to serve as Chair of the Department of Cell Biology.
“I am deeply honored to accept the leadership of MECCC,” said Dr. Steidl. “We have a world-class team composed of exceptional clinicians, researchers, and administrators who are deeply dedicated to our patients, our community, and cutting-edge cancer care and innovative science. I look forward to working together as we advance our mission to reduce the burden of cancer in the Bronx and beyond, and drive innovation that improves the lives and well-being of people in our borough and around the world.”
A National Institutes of Health-funded scientist, Dr. Steidl is internationally recognized for his work on pre-leukemic stem cells and the progression to myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His research has been applied to other tumor types as well, and helped define how MDS and AML develop and contributed to experimental therapies now in clinical trials.
A recipient of major honors from the National Cancer Institute and the International Society for Experimental Hematology, Dr. Steidl is also widely respected for mentorship, with trainees now in leadership roles worldwide.
Learn more here: https://montefioreeinstein.org/news/2026/04/07/ulrich-steidl-md-phd-named-director-montefiore-einstein-comprehensive-cancer-center.
Albert Einstein College of Medicine National Institutes of Health (NIH) National Cancer Institute